This research examines whether metformin, a common diabetes drug, can improve social cognition in individuals with multiple sclerosis by promoting remyelination. Since MS damages nerve insulation, affecting brain function, the study explores whether treating co-occurring diabetes can reduce inflammation and symptoms, potentially leading to new regenerative therapies and improved quality of life.

This research examines how multiple sclerosis disrupts meaning and identity beyond physical symptoms. A nurse-led, group-based intervention helps people with MS rebuild purpose and quality of life. By targeting meaning alongside medical treatment, the project addresses the often-overlooked psychological impact of chronic illness and offers a scalable model for holistic care.